44 results
6-K
EX-99.1
SNY
Sanofi
27 Sep 23
Current report (foreign)
6:06am
investments in the development of adaptation solutions for climate vulnerable communities. All our company commitments are rooted in concrete, transparent
6-K
EX-99.2
SNY
Sanofi
28 Jul 23
Condensed Half-year Consolidated Financial Statements
7:00am
of their Sanofi medicine as they wait for their application to be processed.
Learn more about Sanofi’s transparent approach to pricing in the U.S
6-K
EX-99.1
SNY
Sanofi
27 Apr 23
Strong Q1 growth driven by Specialty Care, Vaccines and CHC
11:39am
, immediate month’s supply of their Sanofi medicine as they wait for their application to be processed.
Learn more about Sanofi’s transparent approach
6-K
EX-99.1
SNY
Sanofi
4 Apr 22
Distribution of Shares of Euroapi
11:21am
%). A supply chain program was designed to guarantee transparent processes throughout the value chain to deliver APIs to the Group’s customers within
6-K
EX-99.2
d6bodnhlv
4 Nov 20
Sanofi offers to acquire Kiadis, a clinical-stage company developing cell-based immunotherapy products
3:27pm